Does the monocyte/lymphocyte ratio predict the presence and severity of coronary artery disease better than the neutrophil to lymphocyte ratio?
The monocyte/lymphocyte ratio may serve as a useful biomarker for predicting the presence and angiographic severity of coronary artery disease.
MLR was an independent risk factor of the presence of CAD, and a predictor of the lesion severity. Compared to neutrophil to lymphocyte ratio (NLR), MLR has better performance to reflect the severity of coronary lesion.
Ji et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: